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The ﬁnding of more severe steatohepatitis in alcohol fed Long Evans (LE) compared with Sprague Dawley (SD) and Fisher 344
(FS) rats prompted us to determine whether host factors related to alcohol metabolism, inﬂammation, and insulin/IGF signaling
predict proneness to alcohol-mediated liver injury. Adult FS, SD, and LE rats were fed liquid diets containing 0% or 37% (calories)
ethanol for 8 weeks. Among controls, LE rats had signiﬁcantly higher ALT and reduced GAPDH relative to SD and FS rats. Among
ethanol-fedrats,despitesimilarbloodalcohollevels,LEratshadmorepronouncedsteatohepatitisandﬁbrosis,higherlevelsofALT,
DNA damage, pro-inﬂammatory cytokines, ADH, ALDH, catalase, GFAP, desmin, and collagen expression, and reduced insulin
receptor binding relative to FS rats. Ethanol-exposed SD rats had intermediate degrees of steatohepatitis, increased ALT, ADH
and proﬁbrogenesis gene expression, and suppressed insulin receptor binding and GAPDH expression, while pro-inﬂammatory
cytokines were similarly increased as in LE rats. Ethanol feeding in FS rats only reduced IL-6, ALDH1–3, CYP2E1, and GAPDH
expression in liver. In conclusion, susceptibility to chronic steatohepatitis may be driven by factors related to eﬃciency of ethanol
metabolism and degree to which ethanol exposure causes hepatic insulin resistance and cytokine activation.
1.Introduction
Chronic alcohol abuse causes liver injury that can progress
through stages of simple steatosis to steatohepatitis, ﬁbrosis,
cirrhosis, and ﬁnally end-stage liver disease, and it also
impairs the regenerative capacity of the liver [1–4]. Ethanol
mediates these eﬀects by compromising insulin signaling,
which is needed for DNA synthesis, cell survival, gene
expression, cell motility, and energy metabolism [5–10].
Insulin functions by activating its own receptor tyrosine
kinase, which transmits signals downstream through insulin
receptor substrate proteins and a complex sequence of
adaptor molecules [11]. Ethanol inhibits at all levels of the
insulin signaling cascade, but importantly, it impairs insulin
receptor binding [12, 13] and activation of insulin receptor
tyrosine kinase [6–9, 14]. Consequently, the toxic/metabolic
eﬀects of ethanol are mediated at proximal points within
the insulin signaling cascade [14, 15], thereby accounting for
the broad range of cellular functions impaired by ethanol
[11], and the varied mechanisms of liver injury including
increasedDNAdamage,activationofproapoptosispathways,
and mitochondrial dysfunction [14, 16, 17].
Previous studies showed that Long Evans (LE) rats were
highly susceptible to the eﬀects of chronic alcohol exposure,
both in terms of liver [14]a n db r a i n[ 18–21] injury. In
contrast to other rodent models in which chronic ethanol
feeding for as long as 30 or 40 weeks results in mild
microsteatosis with minimal inﬂammation, LE rats develop
prominent steatohepatitis with increased DNA damage and
evidence of apoptosis and necrosis within 5 or 6 weeks of
ethanol feeding [12, 14, 15, 22]. Moreover, chronic ethanol
feeding in LE rats causes hepatic insulin resistance with
inhibition of survival signaling [12]. Altogether, the abnor-
malities produced by chronic ethanol exposure in LE rats
resemblehumanchronicalcoholicsteatohepatitis,suggesting
that this model is an excellent tool for exploring means of2 Gastroenterology Research and Practice
preventing or minimizing the long-term consequences of
alcohol-induced liver injury, including deﬁcits in the liver’s
capacity to regenerate.
Empirical observations in our laboratory revealed that
chronic ethanol exposure in other strains, including Sprague
Dawley (SD) and Fisher 344 (FS) rats, did not produce
as robust a model of steatohepatitis compared with LE
rats, raising a fundamental question about the role of
genetic or strain background in relation to host suscep-
tibility to alcohol-mediated liver injury. We hypothesized
that premorbid and/or postethanol exposure diﬀerences
in hepatic insulin responsiveness, alcohol metabolizing
enzyme gene expression, and proinﬂammatory status in liver
would correlate with severity of alcoholic steatohepatitis.
To address this question, we compared liver histology and
several biochemical and molecular parameters of hepatic
dysfunction, including steatosis, insulin and insulin-like
growth factor (IGF) receptor binding, and mRNA levels of
alcohol metabolizing enzymes, proinﬂammatory cytokine,
and hepatic cellular function genes among LE, SD, and FS
rats which were empirically found to diﬀer with respect to
severity of chronic ethanol-induced liver injury. The primary
objective of this study was to determine if the strains diﬀered
signiﬁcantly with regard to these parameters, either before or
after chronic ethanol exposure. The expectation was that if
pre- or postethanol exposure diﬀerences exist and correlate
with injury and functional impairments in liver, future
eﬀorts could be productively directed to identify relevant
biomarkers and design therapies that target fundamental
abnormalities.
2. Methods
2.1. Chronic Ethanol Exposure Model. Adult male (∼200–
250g) FS, LE, and SD rats (Harlan Sprague Dawley, Inc.,
Indianapolis, Indiana) were pair-fed with isocaloric liquid
diets (BioServ, Frenchtown, NJ) for 8 weeks [14]. Two
weeks prior to the experiment, rats were adapted to the
liquid diets by incrementing the ethanol content from 0%
to 11.8%, 23.6%, and then 37% of the caloric content.
Controls were adapted to ethanol-free liquid diets over the
same period. Thereafter, rats were maintained on 0% or
37% ethanol-containing diets throughout the study [14].
Rats were monitored daily to ensure adequate nutritional
intake and maintenance of body weight. Blood alcohol levels
were measured at 8 AM using the Analox GM7 apparatus
(AnaloxInstrumentsUSA,Lunenburg,MA)accordingtothe
manufacturer’s protocol. At the end of the feeding period,
the rats were sacriﬁced by i.p. injection of 120mg/kg sodium
pentobarbital, and liver tissues were snap-frozen in a dry
ice/methanol bath for later protein and RNA studies, or
immersion ﬁxed in Histochoice (Amresco, Solon, OH) for
histological studies. Throughout the experiment, rats were
housed under humane conditions and kept on a 12-hour
light/dark cycle with free access to food. All experiments
were performed in accordance with protocols approved
by Institutional Animal Care and Use Committee at the
Lifespan-Rhode Island Hospital, and conform to guidelines
established by the National Institutes of Health.
2.2. Histopathologic Studies. Paraﬃn-embedded histological
sections were stained with Hematoxylin and Eosin (H&E),
and adjacent sections were stained with Sirius Red F3B
to detect ﬁbrosis, or immunostained to detect single-
stranded DNA as an index of DNA damage [23]. Prior to
immunostaining, the tissue sections were pretreated with
proteinase K and blocked to reduce nonspeciﬁc binding
according to the manufacturer’s protocol. The sections were
immunostained with 1μg/mL of mouse monoclonal anti-
single-stranded DNA antibody (Chemicon, Temecula, CA),
and immunoreactivity was detected with horseradish perox-
idase (HRP)-conjugatedpolymer-tagged secondaryantibod-
ies (Abcam, Cambridge, MA, USA) and diaminobenzidine
as the chromogen. The sections were lightly counterstained
with Hematoxylin. Percentages of labeled cells per 100x
magniﬁcation ﬁeld were determined using Image Pro-3 Plus
software (Media Cybernetics Inc., Bethesda, MD).
2.3. Lipid Assays. Lipid analyses were performed on
chloroform-methanol (2:1) extracted fresh frozen liver
tissue homogenates [24]. Total lipid content was measured
usingaNileRedﬂuorescence-basedassay(MolecularProbes,
Eugene, OR) [25–27], and ﬂuorescenceintensity (Ex 485/Em
572) was measured in a SpectraMax M5 microplate reader
(Molecular Devices Corp., Sunnyvale, CA). Triglycerides and
cholesterol were measured with commercially available assay
kits (Serum Triglyceride Determination kit, Sigma-Aldrich
Co., St. Louis, MO; Amplex Red Cholesterol Assay Kit,
Molecular Probes, Eugene, OR). Results were normalized to
liver sample weight.
2.4. Quantitative Reverse Transcriptase Polymerase Chain
Reaction (qRT-PCR) Assays of Gene Expression. Total RNA
was reverse transcribed with random oligodeoxynucleotide
primers, and the resulting cDNA templates were PCR
ampliﬁed with gene speciﬁc primers [28]( Table 1). Ampli-
ﬁed products were detected and analyzed in triplicate
using the Mastercycler ep realplex instrument and software
(Eppendorf AG, Hamburg, Germany) [24]. Relative mRNA
abundance was calculated from the ng ratios of mRNA
to 18S rRNA measured in the same samples, and those
data were used for intergroup comparisons. Control studies
included analysis of: (1) template-free reactions, (2) RNA
that had not been reverse transcribed, (3) RNA samples
pretreated with DNAse I, (4) samples treated with RNAse A
prior to the reverse transcriptase reaction, and (5) genomic
DNA. Although mRNA levels measured by qRT-PCR can be
compared using various approaches, including the 2−ΔΔCT
method [29], we elected to calculate relative transcript
abundance with 18S rRNA as the denominator because
this approach allows one to more eﬀectively correct for
diﬀerences in template input and diﬀerences in ampliﬁcation
eﬃciency pertaining to rat strain and ethanol exposure [30].
2.5. Enzyme-Linked Immunosorbant Assay (ELISA). Tis-
sues were homogenized in radioimmunoprecipitation assay
buﬀer containing protease and phosphatase inhibitors [31].
Direct binding ELISAs were performed in 96-well platesGastroenterology Research and Practice 3
Table 1: Primer pairs for quantitative RT-PCR assays.
Primer Sequence (5  → 3 ) Position Size (bp)
Desmin For ACCTGCGAGATTGATGCTCT 1069 206
Desmin Rev ACATCCAAGGCCATCTTCAC 1274
COL1a2 For ACCTCAGGGTGTTCAAGGTG 1632 222
COL1a2 Rev CGGATTCCAATAGGACCAGA 1844
α-SMA For TGTGCTGGACTCTGGAGATG 516 148
α-SMA Rev GAAGGAATAGCCACGCTCAG 663
ASBT For GCATTGGCATTTCTCTGGTT 598 181
ASBT Rev GGTTCAATGATCCAGGCACT 778
GFAP For GGTGGAGAGGGACAATCTCA 433 215
GFAP Rev CTCGAACTTCCTCCTCATGG 647
ALB For CTTCAAAGCCTGGGCAGTAG 702 188
ALB Rev TGGAGATAGTGGCCTGGTTC 889
KCR For TCACAAATGCTGTGGACCAT 1427 161
KCR Rev GTCTTCACGCTCTCCGTTTC 1587
ADH-1 For TGCTCCGTGCTGGAAAGAGTATCC 1138 117
ADH-1 Rev TAAGGTTGTGATGTGGCTGGCG 1254
ADH-7 For CAATGCTGCTTTTCACTGGA 971 234
ADH-7 Rev AGAACACCCAGCTCTCTGGA 1204
ALDH-1 For ATCTGCCATGTGGAAGAAGG 173 216
ALDH-1 Rev CAAGTACGCATTGGCAAAGA 388
ALDH-2 For GACCTGGACAAGGCCAATTA 1391 193
ALDH-2 Rev TCTTCTGTGGCACTTTGACG 1583
ALDH-3 For CTGATTGCTGAGGTTCCTGTTAGG 1914 119
ALDH-3 Rev GGATGTTTAGACTGAGAGCCGACTC 2032
Catalase For ATACGAAGGTGTTGAATGAGGAGG 1369 63
Catalase Rev TCAGGTGGTTGGCAATGTTCTC 1431
CYP2E1 For GTGTTCACACTGCACCTTGG 211 69
CYP2E1 Rev CACCTCCTTGACAGCCTTGT 279
GAPDH For AGT GGG CAT CAA TGG ATT TGG 306 241
GAPDH Rev GGG GAT TTC CTT AGG TTC TTT GC 546
IL-1β For CAG CAG CAT CTC GAC AAG AG 233 60
IL-1β Rev CTT CTC CAC AGC CAC AAT GA 292
TNF-α For ATG TGG AAC TGG CAG AGG AG 26 84
TNF-α Rev AGA AGA GGC TGA GGC ACA GA 109
IL-6 For ATG TTG TTG ACA GCC ACT GC 116 51
IL-6 Rev GTC TCC TCTCCG GAC TTG TG 166
qPCR: quantitative polymerase chain reaction; ASBT: apical sodium dependent bile acid transporter; KCR: Kupﬀer cell glycoprotein receptor; GFAP: glial
ﬁbrillary acidic protein; COL1a2: pro-alpha-2(I) collagen; ALB: albumin; α-SMA: alpha smooth muscle actin; ADH: alcohol dehydrogenase; ALDH: aldehyde
dehydrogenase; CYP2E1: cytochrome P450 2E1; GAPDH: glyceraldehyde-3-phosphaye dehydrogenase; IL: interleukin 1; TNF: tumor necrosis factor.
Table 2: Weight gain after 8 weeks on isocaloric liquid diets∗.
FS Control FS Ethanol LE Control LE Ethanol SD Control SD Ethanol
#R a t s / G r o u p 1 2 1 4 1 2 1 3 1 2 1 3
Wt Gain (gm) 82.68 55.49c,d 75.05e 64.18b 104.4 90.88
± S.E.M. 5.35 3.83 6.49 6.92 7.93 6.86
% Wt Gain 30.63 21.16a,b 21.04a,b 19.59a,b 34.75 30.02
S.E.M. 1.98 1.42 1.77 2.32 2.73 2.34
∗Adult Fisher (FS), Long Evans (LE), and Sprague-Dawley (SD) rats were pair-fed with isocaloric control or ethanol-containing liquid diets for 8 weeks,
and were weighed weekly (See Section 2). Net mean body weight (grams) and mean percentage body weight gained over the 8 week period were
calculated. Intergroup comparisons were made using two-way ANOVA and Tukey post hoc tests of signiﬁcance. asigniﬁcantly lower than FS Control
(P<. 05); bsigniﬁcantly lower than SD Control (P<. 001) and SD Ethanol (P<. 05); csigniﬁcantly lower than FS Control (P<. 05); dsigniﬁcantly lower
than SD Control (P<. 001) and SD Ethanol (P<. 01); and esigniﬁcantly lower than SD Control (P<. 05).4 Gastroenterology Research and Practice
Table 3: Insulin and insulin like growth factor receptor saturation binding assay results for liver.
Receptor FS-Control FS-Ethanol LE-Control LE-Ethanol SD-Control SD-Ethanol
Insulin
Bmax 46.61 ± 27.43 99.85 ± 60.68 43.41 ± 24.54 16.9 ± 2.98∗∗ 29.24 ± 14.42 18.94 ± 2.18∗∗∗
Kd 380.7 ± 262.6 1028 ± 666.8 830.9 ± 508.7 228.3 ± 51.03∗∗∗ 716.6 ± 387.1 260.2 ± 37.18∗∗∗
R2 0.8888 0.9799 0.9743 0.972 0.9726 0.9907
IGF-1
Bmax 3.35 ± 0.33 2.13 ± 0.24 5.11 ± 0.83∗∗ 5.42 ± 1.15∗∗∗ 5.13 ± 1.77∗∗∗ 5.02 ± 1.34∗∗∗
Kd 29.45 ± 6.89 9.46 ± 4.20∗∗ 57.34 ± 17.23 88.34 ± 30.31 114 ± 58.96 89.7 ± 38.36
R2 0.8684 0.5333 0.8156 0.8313 0.6977 0.735
IGF-2
Bmax 45.00 ± 4.40 46.36 ± 5.04 12.13 ± 1.41∗∗∗ 38.59 ± 5.19 29.46 ± 2.15∗ 41.29 ± 3.17
Kd 30.28 ± 5.99 24.86 ± 5.87 18.74 ± 5.28∗∗∗ 25.51 ± 7.38 15.95 ± 3.01∗∗∗ 22.43 ± 3.88
R2 0.9099 0.8685 0.8028 0.8131 0.9026 0.9197
Saturation binding assays were performed with liver tissue homogenates from Fisher 344 (FS), Sprague Dawley (SD), or Long Evans (LE) rats maintained
on liquid diets containing 0% (control) or 37% ethanol (caloric content) for 8 weeks. The BMAX (top-level binding), Kd (aﬃnity), and R2 (correlation
coeﬃcient) were calculated using Prism 5 software. Intergroup comparisons of the one-site speciﬁc binding curves were made using extra sum of squares
F-tests. For all groups, the df = 38. ∗P = .0008; ∗∗P = .0002; ∗∗∗P<. 0001 relative to corresponding FS control or ethanol-exposed group.
(Nunc, Rochester, NY) [18]. In brief, proteins (40ng/100μL)
adsorbed to well bottoms by overnight incubation at 4◦C
were blocked with 3% BSA in Tris buﬀered saline (TBS)
and then incubated with primary antibody (0.2–1.0μg/mL)
for 1 hour at room temperature. Immunoreactivity was
detected with horseradish peroxidase- (HRP-) conjugated
secondary antibody (1:10000; Pierce, Rockford, IL) and
Amplex Red soluble ﬂuorophore (Molecular Probes, Eugene,
OR) [18]. Fluorescence was measured (Ex 530/Em 590)
in a SpectraMax M5 microplate reader. Binding speciﬁcity
was monitored in parallel control incubations that included
nonrelevantantibodies, oromittedtheprimary orsecondary
antibody. Immunoreactivity was normalized to protein
content in parallel wells as determined with the NanoOr-
ange Protein Quantiﬁcation Kit (Molecular Probes, Eugene,
OR).
2.6. Receptor Binding Assays. Competitive equilibrium bind-
ing studies were used to measure eﬀects of chronic ethanol
feeding on insulin, IGF-1, and IGF-2 receptor binding [20,
31]. For total binding, NP-40 lysis buﬀer homogenates
were incubated in 100μL reactions containing binding
buﬀer (100mM HEPES (4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonicacid),pH8.0,118mMNaCl,1.2mMMgSO4,
8.8mM dextrose, 5mM KCl, 1% bovine serum albumin)
and 0.0031 to 1μCi/mL of [125I] (2000Ci/mmol) 50nCi/ml
of [125I] (2000Ci/mmol; 50pM) insulin, IGF-1, or IGF-2.
For nonspeciﬁc binding, identical reactions were prepared
with the addition of 0.1μM unlabeled ligand. After 16-
hours incubation at 4◦C, reactions were harvested (Corning,
Lowell, MA) onto 96-well GF/C ﬁlter plates that were
presoaked in 0.33% polyethyleneimine. The ﬁlters were
vacuum washed with 50mM HEPES, pH 7.4, 500mM
NaCl, and 0.1% BSA. [125I]-bound insulin, IGF-1, or IGF-2
was measured in a TopCount (Perkin-Elmer, Boston, MA).
Speciﬁc binding was calculated by subtracting fmol/mg of
nonspeciﬁcally bound isotope from the total bound isotope.
The results were plotted and analyzed using GraphPad Prism
5 software (San Diego, CA).
2.7. Sources of Reagents. Human recombinant [125I]-Insulin,
IGF-1, and IGF-2 were purchased from Amersham Bio-
sciences (Boston, MA). Unlabeled human insulin and
recombinant IGF-1 and IGF-2 were obtained from Bachem
(Torrance, CA). QuantiTect SYBR Green PCR Mix was
obtained from Qiagen, Inc. (Valencia, CA). Unless otherwise
indicated, all other ﬁne chemicals were purchased from
either CalBiochem (Carlsbad, CA) or Sigma-Aldrich (St.
Louis, MO).
2.8. Statistical Analysis. Data depicted in the graphs and
tables represent the means ± S.E.M.’s for 8–12 samples per
group. Intergroup comparisons were made using two-way
ANOVA and the Bonferroni post hoc multiple comparison
test. Statistical analyses were performed using the GraphPad
Prism 5 software (GraphPad Software, Inc., San Diego, CA).
Signiﬁcant P-values are shown in the graphs and tables.
3. Results
3.1. Weight Gain Associated with Liquid Diet Feeding. Rats
in all groups consumed similar quantities of food, and
correspondingly all gained weight over the course of the
study. Despite identical birth weights and ages, FS rats
had the lowest original and ﬁnal body weights, SD rats
were intermediate, and LE’s were the largest. The curves
corresponding to body weight over time were virtually
identical for pair-fed LE rats and SD rats, whereas in FS
rats, the trends were more tapered for ethanol-fed relative
to controls after 3-4 weeks on the liquid diets (Figure 1(a)).
Correspondingly, linear regression analysis of weight gain
over time demonstrated slopes of 9.28 ± 1.49 and 7.77 ±
1.09 for control and ethanol-fed LE rats (P = .42), and
12.63 ± 0.80 and 11.39 ± 0.81 for control and ethanol-fedGastroenterology Research and Practice 5
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Figure 1: Rat strain diﬀerences in eﬀects of chronic alcohol feeding on weight gain, liver injury, and steatosis: Fisher 344 (FS), Long Evans (LE),
and Sprague Dawley (SD) rats were fed with isocaloric liquid diets containing 0% or 37% ethanol (caloric content) for 8 weeks. (a) Weekly
changes in body weight are depicted graphically. (b) Blood alcohol concentrations and (c) serum ALT levels were measured at the time of
sacriﬁce. (d) Nile Red ﬂuorescence (neutral lipids), (e) triglycerides, and (f) cholesterol levels were measured in liver tissue, and results were
normalized to sample weight or protein content. Graphs depict the mean ± S.E.M. Intergroup comparisons were made using ANOVA with
the post hoc Bonferroni multiple comparisons test. Signiﬁcant P-values are indicated within the panels. In addition, ∗P<. 05 relative to FS
control; ∗∗∗P<. 001 relative to FS control; ζζζ P <.001 relative to FS control and ethanol-fed rats.
SD rats (P = .277), reﬂecting the similar within-group mean
percentageincreasesinbodyweight(Table 2).Incontrast,for
the FS strain, the slopes reﬂecting weight gain over time were
11.18 ± 0.82 and 7.74 ± 0.68 for control and ethanol fed rats
(P = .0018), correlating with the signiﬁcant diﬀerences in
their mean percentages of weight gained (Table 2). Among
the 3 ethanol-fed groups, trends in weight gain were similar
for the FS (Slope = 7.74 ± 0.67) and LE (Slope = 7.77 ± 1.09)
strains, and both were signiﬁcantly lower than that measured
for the SD strain (11.39 ± 0.81) (P = .0037). Therefore, FS
and LE rats exhibited similar percentage increases in body
weight, but the ethanol-associated dampening of growth in
FS rats reduced the net weight gained relative to the other
strains. SD rats gained more weight and at faster rates than6 Gastroenterology Research and Practice
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Figure 2: Rat strain diﬀerences in susceptibility to alcohol-induced steatohepatitis: histological sections of liver were stained with (a)–(l) H&E.
Photomicrographs depict livers from (a, c, e, g, i, k) control or (b, d, f, h, j, l) ethanol-exposed (a)–(d) FS, (e)–(h) LE, or (i)–(l) SD rats.
Note more prominent microsteatosis (vacuoles) and apoptosis (arrows) in ethanol-fed LE and SD compared with FS rats, and in ethanol-fed
relativetocontrolrats.Also,notemicrosteatosisinLEcontrollivers(g).Originalmagniﬁcations,Panels((a),(b),(e),(f),(i),(j)):80x,Panels
((c), (d), (g), (h), (k), (l)): 400x, Insets:650x.
the other two groups. Despite these diﬀerences in weight
gained over time, the mean blood alcohol levels were similar
among the ethanol-fed groups (Figure 1(b)). Therefore, any
distinctions found with respect to the eﬀects of chronic
ethanol exposure could not be attributed to diﬀerences in
blood alcohol levels.
3.2. Eﬀects of Ethanol on Biomarkers of Liver Injury and
Steatosis. Among controls, mean serum alanine transami-
nase (ALT) was signiﬁcantly higher in LE compared with
FS rats (Figure 1(c)), indicating higher baseline levels of
hepatocellular injury in the LE strain. Among ethanol-fed
rats, the LE strain also had the highest mean ALT. Although
ethanol feeding increased ALT in all 3 strains relative to
pair-fed controls, the within-group diﬀerences were not
statistically signiﬁcant due to variability in the magnitude
of responses. However, mean ALT was signiﬁcantly higher in
ethanol-fed LE and SD rats than in FS controls.
The Nile red assay was used to quantify hepatic neutral
lipid content (ﬂuorescent light units; FLU) with values
normalized to sample weight (Figure 1(d)). Hepatic Nile red
ﬂuorescence was signiﬁcantly increased by chronic ethanol
exposure in the LE but not in the FS or SD strain. Moreover,
Nile red ﬂuorescence was signiﬁcantly higher in livers of
ethanol-fed LE rats compared to all other groups.
Hepatic triglyceride content was similarly low among
the 3 control groups, and the chronic ethanol-fed FS rats
(Figure 1(e)).Chronicethanolfeedingsigniﬁcantlyincreased
hepatic triglyceride content in LE and SD relative to control
and ethanol-fed FS rats. In addition, hepatic triglycerideGastroenterology Research and Practice 7
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Figure 3: Rat strain diﬀerences in susceptibility to alcohol-induced hepatic ﬁbrosis: histological sections of liver were stained with Sirius red
to detect collagen. Photomicrographs depict livers from (a, c, e) control or (b, d, f) ethanol-exposed (a), (b) FS, (c), (d) LE, or (e), (f) SD
rats. Note more prominent peri-hepatocyte Sirius red-positive collagen ﬁbrils in ethanol-exposed livers and more extensive labeling in LE
compared with FS and SD ethanol-fed rats. Original magniﬁcation: 650x.
content was signiﬁcantly higher in ethanol-fed relative to
c o n t r o lS Dr a t s .T h em e a nh e p a t i cc h o l e s t e r o ll e v e l sw e r e
similar among all groups except the ethanol-fed LE rats, in
whichthemeanlevelwassigniﬁcantlyhigherthaninallother
groups except SD controls (Figure 1(f)).
Histopathological studies demonstrated the expected
regular chord-like architecture with minimal steatosis or
inﬂammation in control FS and SD livers, and mild
microvesicular steatosis in control LE livers (Figure 2).
Chronic ethanol feeding produced subtle increases in hep-
atocellular macrosteatosis with rare foci of lymphomononu-
clear inﬂammation in FS rats, but conspicuously increased
mixed patterns of micro- and macrosteatosis with foci of
inﬂammation and apoptosis in SD rats. LE rats had the
most pronounced histopathological responses to chronic
alcohol exposure characterized by increased disorganiza-
tion of hepatic chord architecture, prominent micro- and
macrosteatosis, and conspicuous foci of inﬂammation and
necrosis or apoptosis. Sirius red-stained sections of liver
revealed minimal collagen ﬁbril deposition in FS controls,
but conspicuously more abundant labeling of coarser peri-
hepatocyte ﬁbrils in LE and SD controls (Figures 3(a), 3(c),
and 3(e)). All 3 strains exhibited increased peri-hepatocyte
collagendeposition following8weeksofethanol feeding,but
t h ed e g r e e sw e r eg r e a t e ri nL Ea n dS Dc o m p a r e dw i t hF S
rats (Figure 3). In addition, LE livers exhibited “chickenwire
ﬁbrosis” characterized by a trabecular or mesh-like pattern
ofﬁbrosiswithcollagenﬁbrilscompletelysurroundingsingle
hepatocytes (Figure 3(d)).
3.3. Eﬀects of Strain and Ethanol on Inﬂammatory Mediators.
To assess the eﬀects of strain and chronic ethanol exposure
on cytokine expression, we used qRT-PCR to measure
interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-alpha
(TNF-α) mRNA levels (Figures 4(a)–4(c)). These proinﬂam-
matory cytokines were investigated because of their known8 Gastroenterology Research and Practice
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Figure 4: Eﬀects of strain and ethanol exposure on proinﬂammatory cytokine gene expression and DNA damage in liver:q R T - P C Rw a su s e d
to measure (a) TNF-α,( b )I L - 6 ,a n d( c )I L - 1 β expression, with results normalized to 18S rRNA. (d) Histological sections of liver were
immunostained to detect single-stranded (SS) DNA as an index of nuclear DNA damage. Graphs depict the mean ± S.E.M. percentages
of labeled hepatocyte nuclei (SS DNA Index). Intergroup comparisons were made using ANOVA with the post hoc Bonferroni multiple
comparisons test of signiﬁcance. Signiﬁcant P-values are indicated within the panels. In addition, ∗P<. 05 and ∗∗∗P<. 001 relative to FS
Control; ζζ P <.01 and ζζζ P <.001 relative to FS control and ethanol fed rats; ψψψ P <.001 relative to FS ethanol-fed rats.
roles in steatohepatitis due to chronic alcohol exposure or
metabolic syndrome [32, 33]. In addition, we quantiﬁed
DNA damage in histological sections by immunostaining for
single-strandedDNAnicksandperformingimageanalysisto
determine the percentages of labeled nuclei (Figure 4(d)). In
FS rats, the mean levels of TNF-α and IL-1β expression were
unchanged by chronic ethanol feeding, whereas IL-6 expres-
sion was signiﬁcantly reduced. In LE rats, chronic ethanol
feeding signiﬁcantly increased expression of all 3 cytokines
relative to the pair-fed controls. In SD rats, chronic ethanol
feeding signiﬁcantly increased TNF-α and IL-1β but not IL-
6 expression relative to control. Among ethanol-fed rats,
the LE and SD strains had similar and signiﬁcantly higher
hepatic expression of all 3 cytokines relative to ethanol-fed
FS rats. In addition, chronic ethanol feeding signiﬁcantly
increased the single-stranded DNA labeling indices in both
LE and SD relative to corresponding and FS control livers.
In the FS strain, single-strand DNA labeling indices were
increased by ethanol exposure, but the diﬀerence from
control did not reach statistical signiﬁcance due to broad
variability in responses.
3.4. Eﬀects of Strain and Chronic Ethanol Exposure on
Alcohol-Metabolizing Enzymes. Ethanol is metabolized to
acetaldehyde by alcohol dehydrogenases (ADH) and cata-
lase, and from acetaldehyde to carbon dioxide and water
via aldehyde dehydrogenase (ALDH) and CYP2E1 [34].
To determine if strain, that is genetic background, mod-
ulates liver capacity to metabolize ethanol, we measured
ADH, ALDH, catalase, and CYP2E1 expression in liver
by qRT-PCR. Exploratory studies showed that rat liv-
ers express ADH1, ADH7, ALDH1-ALDH3, catalase, and
CYP2E1; therefore, our analyses were conﬁned to these
genes. Control rats had similar mean levels of hepatic ADH1
and ADH7 across the strains. Chronic ethanol exposure
signiﬁcantly increased ADH1 and/or ADH7 mRNA levels
in LE and SD livers, but not FS livers (Figures 5(a) and
5(b)).Gastroenterology Research and Practice 9
ζζ
ζζ P<. 01
P<. 001
SD LE Fisher
0
20
40
60
80
A
D
H
1
/
1
8
S
(
×
1
0
−
6
)
(a)
P<. 01
P<. 001
SD LE Fisher
0
2
4
6
8
A
D
H
7
/
1
8
S
(
×
1
0
−
6
)
(b)
P<. 001
P<. 05
ψψ
SD LE Fisher
0
1
2
3
4
5
A
L
D
H
1
/
1
8
S
(
×
1
0
−
6
)
(c)
∗
ζ ζ
P<. 05
P<. 001
P<. 001
SD LE Fisher
0
20
40
60
80
A
L
D
H
2
/
1
8
S
(
×
1
0
−
6
)
(d)
∗∗∗ ∗∗∗
∗∗∗ ∗∗∗
P<. 001 P<. 001
SD LE Fisher
0
2
4
6
8
10
A
L
D
H
3
/
1
8
S
(
×
1
0
−
6
)
(e)
P<. 001
P<. 05
SD LE Fisher
0
30
60
90
120
C
a
t
a
l
a
s
e
m
R
N
A
/
1
8
S
(
×
1
0
−
6
)
(f)
P<. 05
∗∗∗ ∗∗∗
∗∗∗
ψψψ
ψψψ
SD LE Fisher
0
0.05
0.1
0.15
0.2
0.25
C
Y
P
2
E
1
/
1
8
S
(
×
1
0
−
6
)
Control
Ethanol
(g)
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Among controls, ALDH1 expression was similar in FS,
LE, and SD rats, while ALDH2 and ALDH3 expressions
were signiﬁcantly lower in LE and SD relative to FS rats. In
addition, catalase and CYP2E1 expression were signiﬁcantly
lower in SD relative to FS controls. With regard to chronic
ethanol feeding, for the FS strain, the mean levels of ALDH1,
ALDH3, and CYP2E1 were signiﬁcantly reduced, while
ALDH2 and catalase were unchanged relative to control
(Figures 5(c)–5(g)). For the LE strain, chronic ethanol feed-
ing signiﬁcantly increased ALDH1, ALDH2, ALDH3, and
catalase mRNA relative to control, but did not aﬀect CYP2E1
expression. Within the SD strain, chronic ethanol exposure
signiﬁcantly increased catalase expression relative to control,
but had no eﬀect on hepatic expression of ALDH1, ALDH2,
ALDH3, or CYP2E1. Therefore, LE rats were distinguished
from FS and SD rats by their broad upregulation of genes
that control rates of alcohol and acetaldehyde metabolism
following chronic ethanol exposure. Among SD rats, the
ethanol-stimulated increases in ADH and catalase, without
corresponding increases in ALDH expression may reﬂect an
increased tendency to accumulate acetaldehyde in liver. The
signiﬁcant ethanol-mediated downregulation of CYP2E1 in
FS could represent a cytoprotective response, as CYP2E1
promotes oxidative stress in the context of ethanol exposure,
and high levels of the enzyme are cytotoxic to liver cells
[35, 36].
3.5. Eﬀects of Strain and Ethanol Exposure on Insulin and
IGF Receptor Binding. Since one of the major eﬀects
of chronic ethanol exposure is hepatic insulin resistance
leading to impairments in energy metabolism, repair, and
regeneration [12, 13, 37–40], we assessed the inﬂuence
of genetic strain on insulin and IGF receptor binding
in relation to chronic ethanol exposure. We performed
competitive saturation binding assays and calculated the
BMAX (top level binding) and Kd (binding aﬃnity) for
each group (Figure 6 and Table 3). Among controls, the
BMAXs for insulin receptor binding were not distinguished
by strain, whereas with regard to IGF-1, the BMAXs were
signiﬁcantly higher, and for IGF-2, they were signiﬁcantly
reduced in SD and LE relative to FS rats. The Kds for
insulin and IGF-1 receptor binding were similar among the
control groups whereas for IGF-2, the Kds were signiﬁcantly
lower (increased aﬃnity) in SD and LE relative to FS
livers.
In FS rats, chronic ethanol feeding had no signiﬁcant
eﬀect on the BMAX of insulin, IGF-1, or IGF-2 receptor
binding, or the Kd for insulin or IGF-2 receptor binding.
However,chronicethanolfeedingdidsigniﬁcantlyreducethe
Kd,thatis,itincreasedbindingaﬃnityfortheIGF-1receptor
in FS rat livers. In SD and LE rats, the main eﬀect of ethanol
wastosigniﬁcantlyreduceboththeBMAXandKdforinsulin
receptor binding relative to the levels observed in pair-fed
controls, and both control and ethanol-fed FS rats (Table 3).
Although ethanol did not signiﬁcantly alter either the BMAX
or Kd for IGF-1 receptor binding in LE and SD rats, each
of these indices was signiﬁcantly higher than in control and
ethanol-fed FS rats. Paradoxically, chronic ethanol feeding
in LE and SD rats signiﬁcantly increased the BMAX and
Kd for IGF-2 receptor binding relative to pair-fed controls.Gastroenterology Research and Practice 11
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Figure 7:Eﬀectsofstrainandethanolexposureonhepaticgeneexpression:qRT-PCRassayswereusedtomeasure(a)albumin,(b)asialobiliary
salt transporter (ABST), (c) Kupﬀer cell receptor gene, (d) glial ﬁbrillary acidic protein (GFAP), (e) desmin, (f) α-smooth muscle actin
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comparisons were made using ANOVA with the post hoc Bonferroni multiple comparisons test of signiﬁcance. Signiﬁcant P-values are
indicated within the panels. In addition, ζP<. 05, ζζ P <.01 relative to FS control and ethanol fed rats.
Consequently,theethanol-associatedIGF-2receptorBMAXs
and Kds were similar in LE, SD, and FS rat livers (Table 3).
3.6.ConsequencesofChronicEthanolConsumptiononHepatic
Gene Expression in Diﬀerent Rat Strains. We used qRT-PCR
assays to examine strain and ethanol eﬀects on gene expres-
sion corresponding to speciﬁc cell types and functions in
liver (Figure 7). Albumin mRNA, which marks hepatocyte
function, was expressed at similar levels in control FS, LE,
and SD rats. Chronic ethanol feeding had no eﬀect on12 Gastroenterology Research and Practice
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albumin expression in FS rats, but signiﬁcantly increased
the levels in LE and SD rats (Figure 7(a)). Apical sodium-
dependent bile acid transporter (ABST) marks bile duct
epithelial cell function. The lowest ABST expression was
measured in FS control and ethanol exposed livers. Among
controls, there were no signiﬁcant diﬀerences in the mean
levels of ABST. Chronic ethanol exposure signiﬁcantly
increased ABST expression in LE, but not FS or SD rats.
Kupﬀer cell glycoprotein receptor (KCR) marks resident
macrophage abundance. Although the highest levels of
KCR expression were observed in LE rats, the intergroup
diﬀerences were not statistically signiﬁcant. Glial ﬁbrillary
acidic protein (GFAP) is expressed in stellate cells. Alpha-
smooth muscle actin (α-SMA) and desmin, an extracellular
matrix product of stellate cells, report activated stellate cell
function. The control groups had similar mean hepatic
expression levels of GFAP, desmin, and α-SMA. Chronic
ethanol feeding signiﬁcantly increased GFAP and desmin
expression only in LE rats. Otherwise, hepatic mRNA levels
of GFAP, desmin, and α-SMA were not signiﬁcantly modu-
lated with respect to rat strain or ethanol exposure. Finally,
collagen gene expression, which reﬂects ﬁbrogenesis, was
similarly low level in all control groups, and in ethanol-fed
FS rats. However, in LE and SD rats, chronic ethanol feeding
signiﬁcantly increased pro-alpha-2(1) collagen (COL1a2)
gene expression in liver. Therefore, chronic ethanol feeding
signiﬁcantly increased expression of albumin, ABST, desmin,
GFAP, and COL1a2 in LE rats, and albumin and COL1a2 in
SD rats. In contrast, in FS rats, ethanol had no signiﬁcant
eﬀect on the expression levels of any of the hepatic genes
examined.
We measured GAPDH immunoreactivity by ELISA to
assess the eﬀects of strain and ethanol exposure on the
expression of an important insulin-responsive gene. We
simultaneously measured β-actin immunoreactivity as
an e g a t i v ec o n t r o l( Figure 8). Among controls, GAPDH
immunoreactivity was the highest in FS, followed by SD
livers.InLElivers,basalGAPDHexpressionwassigniﬁcantly
lower than in FS control livers. Chronic ethanol feeding
signiﬁcantly suppressed GAPDH expression in FS and SD,
but not LE rats. Nonetheless, following chronic ethanol
exposure, the mean levels of GAPDH were signiﬁcantly
higher in FS than LE or SD livers. The mean hepatic levels
of β-actin were relatively similar among the 3 strains, irre-
spective of ethanol feeding. However, β-actin expression was
signiﬁcantly higher in ethanol exposed relative to control SD
livers.
4. Discussion
This study examined the eﬀects of strain, that is, genetic
background on an array of host factors related to alcohol
metabolism, inﬂammation, and insulin/IGF signaling to
determine if baseline or ethanol-induced diﬀerences predict
proneness to alcohol-mediated liver injury. This work was
inspired by ﬁndings in a previous study demonstrating that
LE rats exhibited conspicuous alcohol-mediated hepatitis
after 6–8 weeks of chronic exposure [12, 14, 22], whereas
in other models, signiﬁcant liver injury mainly occurs when
ethanol exposure is combined with other injurious treat-
ments [41, 42]. Moreover, empirical studies suggested that
FS and SD rats were relatively insensitive to ethanol’s eﬀects
on liver compared with LE rats. Therefore, we generated in
vivo models of chronic ethanol feeding in which rats were
pair-fed for 8 weeks with liquid diets containing 0% or 37%
ethanolbycaloriccontent.Theexpectationwasthatthistype
of investigation would eventually lead to the identiﬁcation
of biomarkers that could be applied to humans, and also
help develop therapeutic approaches which target factors
that increase proneness to progressive alcohol-related liver
disease.
The main ﬁndings in this study were that (1) there
were clear strain diﬀerences concerning susceptibility to
alcohol-mediated liver injury and steatohepatitis that were
not attributable to diﬀerences in blood alcohol levels; (2)
postexposure hepatic insulin resistance, characterized byGastroenterology Research and Practice 13
reduced insulin receptor binding and insulin responsive gene
expression, for example, GAPDH, correlated with enhanced
susceptibility to alcohol-induced liver injury; (3) ethanol-
induced increases in proinﬂammatory and pro-ﬁbrogenic
genes correlated with severity of steatohepatitis; (4) resis-
tance to chronic alcohol-induced liver injury in FS rats
was associated with minimal or negative (inhibitory) mod-
ulation of alcohol-metabolizing genes, particularly ADH1
and CYP2E1. Of note is that downregulation of ADH1
wouldservetoreduceacetaldehydegenerationwhilereduced
CYP2E1 would be protective against oxidative injury in
the liver [35, 43]. Moreover, recent studies showed that
chemical inhibition of CYP2E1 and other alcohol metaboliz-
ing enzymes reduces alcoholic steatohepatitis by decreasing
triglyceride accumulation and proinﬂammatory cytokine
levels in liver [44]. In essence, the FS strain appears to harbor
an endogenously (genetically) favorable physiological state
that protects the liver from alcohol-mediated injury, and
utilizes mechanisms that could be exploited for therapeutic
gains.
Despite similar mean blood alcohol levels, histopatho-
logic studies demonstrated that LE rats developed chronic
alcohol-induced liver injury characterized by micro- and
macrosteatosis, multifocal lymphomononuclear inﬂamma-
tion and necrosis/apoptosis, increased single-strand DNA
labeling, that is DNA damage, and loss of the regular
chord-like architecture. Livers of ethanol fed FS rats exhib-
ited minimal injury and steatosis with relative preserva-
tion of hepatic chord architecture, whereas in SD rats,
chronic ethanol feeding produced levels of steatohepatitis
that were intermediate between LE and Fisher rats. Cor-
respondingly, the serum ALT levels and degrees of triglyc-
eride and cholesterol accumulation in liver were highest
in ethanol-fed LE, followed by SD rats. Moreover, proin-
ﬂammatory cytokine gene expression was sharply increased
by chronic ethanol exposure in LE and SD, but not FS
rats.
Since blood alcohol levels were similar in the 3 strains,
the strain-related adverse eﬀects of ethanol most likely mark
inherent (genetic) diﬀerences in susceptibility to alcohol-
mediated liver injury. Of particular note is that we detected
several baseline (nonethanol exposure related) abnormalities
consisting of higher levels of serum ALT, hepatic cholesterol,
DNA damage, and IL-1β mRNA, and lower levels of insulin
receptor binding (BMAX) and aﬃnity (higher Kd), and
insulin responsive gene expression (GAPDH), consistent
with insulin resistance, in LE compared with FS rats who
proved to be fairly resistant to ethanol-mediated liver injury.
This suggests that individuals at increased risk for devel-
oping signiﬁcant and possibly progressive alcohol-related
liver disease may manifest evidence of low-level ongoing
hepatocellular injury, inﬂammation, and insulin resistance,
together with increased cholesterol content in liver, and
therefore could potentially be identiﬁed prior to signiﬁcant
alcohol exposure.
Our studies also showed that the ethanol-induced
expression levels of multiple genes that regulate alcohol
metabolism, including CYP2E1, were correlated with sever-
ity of steatohepatitis, that is, they were highest in LE,
intermediate and variable in SD, and lowest in FS rats. To
some extent, this result is at variance with a recent report
by Ciuclan et al. in which downregulation of ADH by TGF-
β1 was correlated with increased hepatocellular injury [45].
However, the diﬀerences might be explained by the fact that
the responses were demonstrated using relatively short-term
isolated hepatocyte cultures, and the overall goal of their
experiment was to examine how TGF-β1 enhances ethanol-
induced hepatotoxicity. Therefore, TGF-β1 was the main
independent variable in the paper by Ciuclan et al., whereas
chronic ethanol exposure was the primary independent
variable in the present work. Finally, the ﬁndings herein
suggest that diﬀerences in response to ethanol may vary
according to genetic factors, including strain or species.
The diﬀerences observed among the 3 strains with
respect to ethanol’s eﬀects on alcohol-metabolizing enzyme
gene expression could reﬂect inherent diﬀerences in alcohol
metabolism eﬃciency, with higher levels of gene expression
being required to detoxify ethanol in LE than in FS
rats. Consequences of ineﬃcient alcohol metabolism would
include increased acetaldehyde build-up and oxidative stress.
In addition, the relatively higher levels of CYP2E1 expression
in ethanol-exposed LE compared with ethanol-exposed FS
livers may have contributed to the increased severity of
steatohepatitis in LE rats because high levels of CYP2E1
promote oxidative stress and reduce fatty acid oxidation
via inhibition of PPAR-α expression, and thereby enhance
ethanol-induced hepatic steatosis [43]. Correspondingly, the
ethanol-induced downregulation of CYP2E1 expression in
the FS strain could represent an inherent cytoprotective
response, abrogating the cytotoxic eﬀects of ethanol on liver
cells [35, 36].
To better understand the contributions of insulin and/or
IGF resistance in the pathogenesis of alcohol-induced
chronic liver disease, we measured insulin, IGF-1, and IGF-2
receptor binding. Those investigations mainly demonstrated
reduced insulin receptor binding in ethanol-exposed LE
and SD relative to FS livers. Likewise, GAPDH, which is
regulated by insulin [46], was expressed at lower levels in
ethanol-exposed SD and LE compared to FS livers. The
ﬁnding of reduced GAPDH expression in control LE rats
further suggests impairments in hepatic insulin signaling in
this strain at baseline, despite relatively preserved insulin
receptor binding. These results corroborate the concept that
chronic ethanol exposure causes hepatic insulin resistance.
Furthermore, the ﬁndings suggest that endogenous/genetic
factors dictate the degree to which chronic ethanol exposure
willlikelycausesteatohepatitisandhepaticinsulinresistance.
With regard to IGF-1 receptor binding, the major
inﬂuence of strain was to signiﬁcantly lower the binding
aﬃnity in SD and LE rats, with or without chronic ethanol
exposure. Since IGF-1 is an important regulator of hepa-
tocellular growth and repair, IGF-1 resistance would likely
contribute to impaired regenerative and reparative capacity
of the liver. The ﬁnding that SD and LE controls had
signiﬁcantlylowerBMAXsforIGF-2receptorbindinginliver
relative to FS controls supports the notion that endogenous
inter-strain diﬀerences pertain to both basal and ethanol-
induced diﬀerences in insulin/IGF signaling mechanisms14 Gastroenterology Research and Practice
in the liver. On the other hand, the ethanol-associated
normalization of IGF-2 receptor BMAX in SD and LE livers
is of interest in light of the coexisting impairments in insulin
and IGF-1 receptor binding, as IGF-2 can crosstalk with
insulin and IGF-1 signaling pathways [47]. Consequently,
the ethanol-associated enhancements of IGF-2 receptor
binding could represent compensatory responses that aided
in maintaining survival and metabolic functions in ethanol-
exposed LE and SD livers.
Finally, in LE rats, chronic ethanol exposure signiﬁcantly
increased expression of ABST, GFAP, desmin, and collagen,
indicating that bile duct epithelium and stellate cells were
more activated, and that genes responsible for hepatic
ﬁbrosis, that is, desmin and collagen, were up-regulated. In
our models, α-SMA, the most widely used marker of early
stellate cell activation which marks transition from quies-
cence to a contractile myoﬁbroblast phenotype [48, 49], was
expressed in livers from all groups. Although α-SMA mRNA
levels were not signiﬁcantly increased by chronic ethanol
exposure, 3 other indices of the pro-ﬁbrogenic state were
increased in LE rats, correlating with the increased Sirius
Red staining of collagen in liver. Previously it was shown
that increased GFAP expression marks activated stellate cells
in rat liver [50], and increased levels correlate with hepatic
ﬁbrosis in human livers [51], consistent with the ﬁndings
herein. Moreover, cells other than stellate cells, including
portal ﬁbroblasts and bone marrow derived cells contribute
to hepatic ﬁbrosis [48]. Activation of stellate and other
extracellular matrix producing cells with attendant increased
expression of pro-ﬁbrogenesis genes most likely reﬂects a
tendency for the alcohol-induced steatohepatitis to progress
to hepatic ﬁbrosis and liver dysfunction. Although stellate
cell activation and ﬁbrogenesis are known consequences
of chronic alcohol abuse in humans [52–54], our results
link genetic factors and ethanol-mediated insulin/IGF-1
resistance to severity of steatohepatitis and proneness to
develop progressive alcoholic liver disease.
An important and novel conclusion from these studies is
that low levels of chronic injury, inﬂammation, and insulin
resistance in the “normal” or baseline state of liver function
could play a critical role in predisposing individuals to
alcohol-induced chronic liver disease. A second point is
that ethanol-induced stimulation of alcohol-metabolizing
enzymes, or downregulation of CYP2E1, distinguishes the
3 rat strains according to their diﬀerential susceptibili-
ties to chronic alcohol-mediated liver injury. Third, the
degrees to which GFAP, desmin, and collagen 1 expression,
that is indices of ﬁbrogenesis, were increased by chronic
ethanol exposure correlated with inherent strain sensitiv-
ity to ethanol-induced liver injury. These results suggest
that future investigations should focus on both basal and
ethanol-induced abnormalities in liver function including
insulin responsiveness, cell turnover, inﬂammation, alcohol
metabolizing enzyme gene expression, and pro-ﬁbrogenesis
pathways. Furthermore, our ﬁndings suggest that additional
biomarkers that report mild insulin resistance, injury, and
proinﬂammatory states in liver may help predict long-term
adverse responses to alcohol, and possibly other drugs that
utilize alcohol detoxiﬁcation pathways.
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